- Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
-
Cho YM, Wideman RD, Kieffer TJ
- KMID: 2169303
- Endocrinol Metab.
- 2013 Dec;28(4):262-274.
- doi: 10.3803/EnM.2013.28.4.262
Glucagon-like peptide 1 (GLP-1) is secreted from enteroendocrine L-cells in response to oral nutrient intake and elicits glucose-stimulated insulin secretion while suppressing glucagon secretion. It also slows gastric emptying, which... -
- CITED
-
- Close
- SHARE
-
- Close
